In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAIL-encoding retrovirus

Author：                      

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.4, Iss.6, 2012-01, pp. : 1254-1258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1

By          

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1681-1686

Spandidos Publications

Access to resources Recommend Favorite

Combination of HSV1-TK/shTERT by retrovirus vector inhibits hepatocellular carcinoma cell growth in vitro and in vivo

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1307-1313

Spandidos Publications

Access to resources Recommend Favorite

Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1371-1378

Spandidos Publications

Access to resources Recommend Favorite

Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling

By          

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1401-1409

Spandidos Publications

Access to resources Recommend Favorite

In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin

By    

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 975-981

Spandidos Publications

Access to resources Recommend Favorite